Programme

09:00 – 12:00
Pre-Congress Course: Clinical & Laboratory Perspectives on HIT and APS
A comprehensive review of current diagnostic strategies, laboratory methodologies, and their implications for clinical management
Course leaders: Julieta Bomfim & Per Öst

11:00 – 12:00
Nordic Hemophilia Council’s Annual General Meeting
Chair: Eva Zetterberg, Skåne’s University Hospital
Official notice will be issued separately.

11:00 – 13:30
Registration and Exhibition Opens

12:30 – 13:15
Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Novo Nordisk/TBD    

• Takeda/TBD  

13:30 – 13:45
Welcome and Opening Remarks
Speaker: Maria Bruzelius

13:45 – 15:00
Liver Disorder – Haemostasis and Thrombosis
Chairs: Maria Magnusson & Hans Hemmingsson
Speakers:

• 13:50-14:15: Guidelines on Portal Vein Thrombosis / Virginia Hernandez-Gea, Spain

• 14:15-14:30: Novel haemostatic assays and biomarkers in patients with liver cirrhosis, the HELICS project / Sanna Norén, Karolinska Institutet/

• 14:30-14:50: Multidisciplinary patient case on Kasabach-Merritt Syndrome / Hans Hemmingsson, Marie Sund and Tatiana von Bahr Greenwood, Karolinska Institutet

• 14:50-15:00: Q&A

15:00 – 15:30
Coffee Break – Exhibition Area

15:30 – 16:45
Platelet Disorders and treatment
Chairs: Charlotte Gran & David Schmidt
Speakers:

• 15:35-16:05: An update on Glanzmann Thrombasthenia / Roger Schutgens, Utrecht, The Netherlands

• 16:05-16:20: Platelet function testing by flow cytometry in clinical settings – possibilities and challenges / Sofia Ramström, Örebro University, Sweden

• 16:20-16:35: Improving diagnostic work-up of platelet function disorders / David Schmidt, Local Faculty

• 16:35-16:45: Q&A

17:00 – 17:45
Guided Poster Walk
Chairs: Margareta Holmström, Andries Blokzijl & David Schmidt

17:00 – 19:00
Reception – Exhibition Area

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45
Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Pfizer/From Trial to Treatment Centre: Marstacimab OLE Updates and Practical Insights from the Clinic

09:00 – 10:15
Haemophilia and bleeding disorders in clinical practice
Chairs: Susanna Ranta & Petra Elfvinge
Speakers:

• 9:05-9:35: Experience with novel treatment options in haemophilia in Germany / Christoph Königs, Frankfurt, Germany

• 9:35-9:50: FVIII-Mimetic Treatment in Acquired Haemophilia A: Insights from the Karolinska Experience / Maria Bruzelius, Local Faculty

• 9:50-10:05: Building psychological resilience in patients with chronic disease / Karl Björk, Karolinska Institutet

• 10:05-10:15: Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Haemophilia – Laboratory Insights
Chairs: Maria Farm & Niklas Bark
Speakers:

• 10:45-10:55: Evolution of the Chromogenic Assays / Niklas Bark, Local Faculty

• 10:55-11:25: Assessing Haemostatic Function in Emerging Non-Factor Therapies for Hemophilia / Peter Lenting, Paris, France

• 11:25-11:35: Estimating the Haemostatic Capacity in Patients with Emicizumab / Adrian Kimiaei, Local Faculty

• 11:35-11:50: Clinical Outcomes of Emicizumab Monitoring at Karolinska / Tony Frisk, Local Faculty

• 11:50-12:00: Q&A

12:00 – 13:15
Lunch Break – Exhibition Area

12:20 – 13:05
Industry-sponsored mini-sessions

Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Roche/TBD 
• Sobi/TBD 

13:15 – 14:30

Thrombosis Over Time: Risk Factors, Acute Events and Residual Disease

Chairs: Joel Ohm & Tony Frisk
Speakers:

• 13:20-13:50: A new era with bioidentical oestrogens – balancing benefits and thrombotic risk / Kristina Gemzell Danielsson, Karolinska Institutet

• 13:50-14:05: Pulmonary embolism as a cause of cardiac arrest and death: age and sex differences / Emma Bendz, Karolinska Institutet

• 14:05-14:20: Magnetic Resonance Direct Thrombus Imaging / Gargi Gautam, Karolinska Institutet

• 14:20-14:30: Q&A

14:30 – 15:00
Coffee Break – Exhibition Area

15:00 – 16:15

Complexity in Thrombosis: Life-Course Determinants and Clinical Practice

Chairs: Natali Karandyszowska & Emma Skau
Speakers:

• 15:05-15:25: Health equity in childhood and cardiovascular disease / Per Svensson, Karolinska Institutet

• 15:25-15:45: Prosthetic heart valve thrombosis / Mika Skeppholm, Karolinska Institutet

• 15:45-16:05: Primary subclavian vein thrombosis – results of treatment with early catheter-directed thrombolysis followed by decompression of the thoracic outlet / Jonas Malmstedt, Karolinska Institutet

• 16:05-16:15: Q&A

16:15 – 16:30
Break – Exhibition Area

16:30 – 17:30

War, crises and haemostatic challenges

Chairs: Marjan Shafaati Lambert & Torsten Dahlén

Speakers:

• 16:30-16:50: Blood preparedness in emergencies / Agneta Wikman, Karolinska Institutet

• 16:50-17:10: Pre-hospital blood for civilian trauma in conflicts / Johan von Schreeb, Karolinska Institutet

• 17:10-17:30: Challenges in blood transfusion when resources are limited / Märit Halmin, Karolinska Institutet

19:00 –
Congress Dinner

08:00 – 09:00
Poster viewing and exhibition visit

08:00 – 08:45

Industry-sponsored mini-sessions
Each session is limited to 25 participants. Registration links will be made available before the congress begins.

• Bayer/TBD

09:00 – 10:15

Cancer Associated Thrombosis – from mechanism to treatment
Chairs: Roza Chaireti & Axel Rosell

Speakers:

• 09:05-09:35: TBD / Anna Falanga, Milano, Italy

• 09:35-09:45: Venous thromboembolism as the first sign of malignancy / Axel Rosell, Local Faculty

• 09.45-09:55: Coagulopathy in childhood acute lymphoblastic leukemia / Lovisa Malmqvist, Karolinska Institutet

• 09:55-10:05: Neutrophil extracellular trap formation in myeloproliferative neoplasms / Ingrid Lundahl, Karolinska Institutet

• 10:05-10:15: Q&A

10:15 – 10:45
Coffee Break – Exhibition Area

10:45 – 12:00

Von Willebrand Disease
Chairs: Anna Ågren & Adrian Kimiaei

Speakers:

• 10:50-11:20: von Willebrand Disease: Linking Pathophysiology, Diagnostics, and Patient Management / Omid Seidizadeh, Milano, Italy 

• 11:20-11:35: Insights from Approximately 300 von Willebrand Disease Genetic Investigations / August Lundholm, Local Faculty

• 11:35-11:50: Acquired von Willebrand Disease / Anna Ågren, Local Faculty

• 11:50-12:00: Q&A

• 11:50-12:00: Q&A

12:00 – 12:30

Poster Award and Closing Remarks

Speaker: Maria Bruzelius